CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis	CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Not yet recruiting	Phase 1 / Phase 2	2026-08-10		NCT07756268

Clinical trials